Lendormin D® Tablet (Drug Use Result Survey)

Boehringer Ingelheim

Status: Completed

Conditions: Sleep Initiation and Maintenance Disorders

Treatments: Drug: Lendormin D tablets

Study type: Observational

Funder types: Industry

Identifiers

NCT02224014

263.509

Details and patient eligibility

About

Study to investigate the safety and the efficacy in patients with insomnia, receiving Lendormin D tablet under condition of normal clinical practice.

Enrollment: 485 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with insomnia

Exclusion criteria

• none

Trial design

485 participants in 1 patient group

Lendormin D tablets

Treatment:

Drug: Lendormin D tablets